These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 26167077)

  • 1. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
    Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combretum lanceolatum flowers ethanol extract inhibits hepatic gluconeogenesis: an in vivo mechanism study.
    Siqueira JT; Batistela E; Pereira MP; da Silva VC; de Sousa Junior PT; Andrade CM; Kawashita NH; Bertolini GL; Baviera AM
    Pharm Biol; 2016 Sep; 54(9):1671-9. PubMed ID: 26864726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
    Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
    Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
    Yin Y; Fang Z; Wu Y; You L
    J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
    Bang S; Chen Y; Ahima RS; Kim SF
    Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
    Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
    J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
    Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
    Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression.
    Sajan MP; Ivey RA; Farese RV
    Diabetologia; 2013 Nov; 56(11):2507-16. PubMed ID: 23933835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amarogentin ameliorates diabetic disorders in animal models.
    Niu HS; Chao PC; Ku PM; Niu CS; Lee KS; Cheng JT
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1215-1223. PubMed ID: 27485449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats.
    Song D; Yin L; Wang C; Wen X
    BMC Complement Med Ther; 2020 Jan; 20(1):27. PubMed ID: 32020874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guava leaf inhibits hepatic gluconeogenesis and increases glycogen synthesis via AMPK/ACC signaling pathways in streptozotocin-induced diabetic rats.
    Vinayagam R; Jayachandran M; Chung SSM; Xu B
    Biomed Pharmacother; 2018 Jul; 103():1012-1017. PubMed ID: 29710658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
    Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
    Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.
    Koo SH; Flechner L; Qi L; Zhang X; Screaton RA; Jeffries S; Hedrick S; Xu W; Boussouar F; Brindle P; Takemori H; Montminy M
    Nature; 2005 Oct; 437(7062):1109-11. PubMed ID: 16148943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
    Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
    J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model.
    Ren T; Ma A; Zhuo R; Zhang H; Peng L; Jin X; Yao E; Yang L
    J Pharmacol Exp Ther; 2020 Apr; 373(1):81-91. PubMed ID: 32024803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
    Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
    Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.